Demand for chemotherapy is growing, with over four million new cancer patients in Europe each year1. The annual spend in Europe on cancer drugs is €32 billion and increasing fast2.
Ensuring healthcare organisations and professionals can help meet these growing demands, whilst also facing additional pressures such as staff shortages and tightening budgets, can be a challenge.
Prescribing, compounding and administration processes within oncology are often disconnected. Manual processes and paper-based systems can result in poor flow of information and miscommunication. This can lead to medication errors, delays in treatment and poor patient outcomes. There is also a risk to healthcare workers from hazardous drug exposure.
Transform your pathway with BD Oncology Solutions.
A suite of solutions for prescription, compounding, and administration.
With complex clinical decision processes and increasing amounts of individualised chemotherapy required for cancer patients. BD Cato™ Prescribe** reduces the risk of prescribing errors and supports effective treatment decisions.
BD Cato™ Pharmacy reduces chemotherapy compounding errors and improves process efficiency. Barcode scanners, gravimetric verification and image capture are used to ensure correct drug preparation. With information and hard stops if errors are detected.
BD Cato™ Pharmacy provides clear, step-by-step instructions, guiding the user through the compounding process and reduces pharmacy drug expenditure and it optimises the use of the drug and minimises error and in turn reduces pharmacy drug expenditure and to help ensure a safe working environment for staff, by using the closed system transfer device, BD PhaSeal™, you can reduce the risk of hazardous drug exposure during the compounding process.
BD oncology solutions can also be used to reduce errors and improve efficiency for nurses during the drug administration process. BD Cato™ ReadyMed helps to ensure the nurse gives the right drug to the right patient and, through the automatic documentation of drug administration, at the right time. BD Cato™ ReadyMed has been shown to save over three hours of nursing time daily in the hospital oncology day unit.3
BD BodyGuard™ Duo has two independent channels that provide concurrent flow capability, which can help to save nursing time. Using BD’s MicroBore™ sets has direct benefits to the patient, by reducing the volume needed to flush the line before secondary administration.
By connecting and automating workflows, you can minimise safety failures, unlock hidden capacity to treat more patients, and help to protect health care workers.
Unmistakably BD Oncology.
Contact us